A Bayesian multi-risks survival (MRS) model in the presence of double censorings. Read more about A Bayesian multi-risks survival (MRS) model in the presence of double censorings.
Determining the Number of Latent Factors in Statistical Multi-Relational Learning. Read more about Determining the Number of Latent Factors in Statistical Multi-Relational Learning.
Estimating the subgroup and testing for treatment effect in a post-hoc analysis of a clinical trial with a biomarker. Read more about Estimating the subgroup and testing for treatment effect in a post-hoc analysis of a clinical trial with a biomarker.
A varying-coefficient generalized odds rate model with time-varying exposure: An application to fitness and cardiovascular disease mortality. Read more about A varying-coefficient generalized odds rate model with time-varying exposure: An application to fitness and cardiovascular disease mortality.
Rapid enrollment design for finding the optimal dose in immunotherapy trials with ordered groups. Read more about Rapid enrollment design for finding the optimal dose in immunotherapy trials with ordered groups.
LINEAR HYPOTHESIS TESTING FOR HIGH DIMENSIONAL GENERALIZED LINEAR MODELS. Read more about LINEAR HYPOTHESIS TESTING FOR HIGH DIMENSIONAL GENERALIZED LINEAR MODELS.
Analysis of secondary phenotypes in multigroup association studies. Read more about Analysis of secondary phenotypes in multigroup association studies.
Bayesian design of biosimilars clinical programs involving multiple therapeutic indications. Read more about Bayesian design of biosimilars clinical programs involving multiple therapeutic indications.
Endpoint surrogacy in oncological randomized controlled trials with immunotherapies: a systematic review of trial-level and arm-level meta-analyses. Read more about Endpoint surrogacy in oncological randomized controlled trials with immunotherapies: a systematic review of trial-level and arm-level meta-analyses.
Enriched biomarker-driven clinical trials. Read more about Enriched biomarker-driven clinical trials.
